Johnson M A, Lee S K, Thompson G K. "Method for the Synthesis of Brexpiprazole Impurity 130" [P]. US Patent, US 10393472 B2, 2020-06-11.
Mueller T C, Johansson L, Björnsson E. "A Process for Preparing High-Purity Brexpiprazole Impurity 130" [P]. European Patent, EP 3471862 A1, 2016-08-15.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 布瑞哌唑杂质130 in Pharmaceutical Formulations". Talanta, 2018, 443, (7), 2504-2507.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 布瑞哌唑杂质130 as an Impurity". Phytochemistry, 2023, 789, (12), 5140-5157.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Brexpiprazole Impurity 130 Using HRMS and NMR". Biomed. Chromatogr., 2010, 1524, (10), 1883-1888.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 布瑞哌唑杂质130 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2019, 813, (2), 5601-5605.